Tokyo, Aug. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058781) titled 'Pathophysiological Analysis of Esophageal Motility Disorders Using Autoantibody Biomarkers and Exploration of Novel Biomarkers' on Aug. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University Hospital
Condition:
Condition - Patients with esophageal motility disorders such as achalasia and diffuse esophageal spasm
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to perform the MUSCAT Assay (Multiple S-cationized antigen beads array assay) using plasma from patients with esophageal motility disorders, in order to identify markers useful for the diagnosis of esophageal motility disorders.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients scheduled for blood tests, including those with and without esophageal motility disorders
Key exclusion criteria - Women who are pregnant or may be pregnant
Target Size - 250
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 25 Day
Date of IRB - 2025 Year 07 Month 25 Day
Anticipated trial start date - 2025 Year 08 Month 13 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067213
Disclaimer: Curated by HT Syndication.
